Financials Zhejiang Tianyu Pharmaceutical Co., Ltd.

Equities

300702

CNE1000034X1

Pharmaceuticals

End-of-day quote Shenzhen S.E. 23:00:00 15/05/2024 BST 5-day change 1st Jan Change
20.69 CNY -0.77% Intraday chart for Zhejiang Tianyu Pharmaceutical Co., Ltd. +0.63% -4.70%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 9,134 17,038 16,825 8,880 7,555 7,116 -
Enterprise Value (EV) 1 9,134 17,038 16,825 8,880 7,555 7,116 7,116
P/E ratio 15.6 x 25.5 x 81.9 x -75.1 x 271 x 26 x 22.5 x
Yield - 0.53% 0.21% - 0.23% 0.53% 1.06%
Capitalization / Revenue 4.33 x 6.58 x 6.61 x 3.33 x 2.99 x 2.45 x 2.12 x
EV / Revenue 4.33 x 6.58 x 6.61 x 3.33 x 2.99 x 2.45 x 2.12 x
EV / EBITDA 11.5 x 18.7 x 38.8 x 58 x 20.6 x 12 x 10.7 x
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Price to Book 4.48 x 6.42 x 4.54 x 2.54 x 2.17 x 1.92 x 1.73 x
Nbr of stocks (in thousands) 328,031 328,002 347,977 347,977 347,977 343,927 -
Reference price 2 27.84 51.94 48.35 25.52 21.71 20.69 20.69
Announcement Date 23/04/20 19/04/21 21/04/22 26/04/23 25/04/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 2,111 2,587 2,545 2,667 2,527 2,908 3,352
EBITDA 1 792.6 912.5 434.1 153.1 366.1 595 665.5
EBIT 1 688.3 775.7 240.1 -101.8 70.75 321 373
Operating Margin 32.61% 29.98% 9.43% -3.82% 2.8% 11.04% 11.13%
Earnings before Tax (EBT) 1 684.1 768.9 218.4 -110.5 71.92 319.3 370.7
Net income 1 585.7 667.1 204.7 -119 27.36 277 320.7
Net margin 27.75% 25.78% 8.04% -4.46% 1.08% 9.53% 9.57%
EPS 2 1.789 2.033 0.5900 -0.3400 0.0800 0.7967 0.9200
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share 2 - 0.2778 0.1000 - 0.0500 0.1100 0.2200
Announcement Date 23/04/20 19/04/21 21/04/22 26/04/23 25/04/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 S1
Net sales -
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 68.11
Net margin -
EPS 2 0.2000
Dividend per Share -
Announcement Date 28/08/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) 33.7% 28.5% 5.65% -3.29% 0.78% 7.33% 7.77%
ROA (Net income/ Total Assets) - 17.3% 3.83% - - 3.9% 2.7%
Assets 1 - 3,865 5,345 - - 7,103 11,877
Book Value Per Share 2 6.210 8.090 10.70 10.00 10.00 10.80 12.00
Cash Flow per Share 2 1.300 1.900 -0.7500 -0.1400 -0.1300 0.9200 1.540
Capex 1 353 505 736 523 313 103 154
Capex / Sales 16.74% 19.53% 28.9% 19.61% 12.39% 3.54% 4.6%
Announcement Date 23/04/20 19/04/21 21/04/22 26/04/23 25/04/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
20.69 CNY
Average target price
22.6 CNY
Spread / Average Target
+9.23%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300702 Stock
  4. Financials Zhejiang Tianyu Pharmaceutical Co., Ltd.